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Nucleotide Oligomerization Domain 2 (Nod2) Is Not Involved
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Nucleotide-binding oligomerization domain 2 (Nod2) pathways are known to interact with Toll-like receptor
2 (TLR2) and TLR4, which are pattern recognition receptors for Candida albicans. We observed that the
prevalence of Nod2 polymorphisms was not increased in patients with Candida infections. Candida-induced
cytokine production in individuals with Nod2 polymorphisms was unaffected. We conclude that Nod2 is
unlikely to play an important role in the recognition of Candida albicans.
Candida albicans is a major fungal pathogen which causes
invasive bloodstream infections in immunocompromised hosts
(5), as well as mucosal infections, such as recurrent vulvovag-
inal candidiasis (RVVC) in women. Despite the importance of
C. albicans in causing disease, little is known of how it is
recognized by cells and how the innate immune system mounts
an effective defense. Recently, a role for Toll-like receptor 2
(TLR2) and TLR4 in innate immunity against C. albicans has
been established (9).
Analogous to the essential extracellular recognition func-
tions mediated through TLRs (1), another important class of
pattern recognition receptors comprises the nucleotide olig-
omerization domain (Nod) and caspase recruitment domain
proteins, which are responsible for the intracellular recogni-
tion of microbial components like peptidoglycan (PGN) (4). It
has been shown that homozygosity for the 3020insC frameshift
variant of Nod2 gene is associated with decreased NF-B
translocation after stimulation with peptidoglycan, leading to a
decreased proinflammatory cytokine response (3). Patients ho-
mozygous for the 3020insC frameshift mutation are at high risk
for the development of Crohn’s disease (10). Recent data have
shown that Nod2 modulates TLR2 signaling (13), and we have
demonstrated synergistic effects of Nod2 with TLR2 and TLR4
(8). We therefore hypothesized that Nod2 contributes to the
recognition of C. albicans by modulating TLR2- and TLR4-
dependent Candida recognition.
In the present study, we have investigated whether Nod2 is
involved in the recognition of C. albicans by using two exper-
imental approaches. We assessed the prevalence of Nod2 poly-
morphisms in patients with Candida bloodstream infections
and in patients with RVVC and investigated the role of Nod2
in cytokine stimulation by C. albicans blastoconidia.
Nod2 genotyping. Nod2 genotyping was performed for 40 non-
neutropenic individuals who had Candida bloodstream infections
(defined by at least one positive blood culture and clinical signs of
infection) and 15 women with recurrent vulvovaginal candidiasis
who had had more than three culture-proven symptomatic epi-
sodes of a vulvovaginal Candida infection during a 12-month
period. The 51 healthy volunteers were blood donors at Radboud
University Nijmegen Medical Center.
DNA was extracted from whole blood by standard proce-
dures. Genotyping was performed by multiplex pyrosequenc-
ing (11). Amplification of fragments containing the polymor-
phic sites 2104C3T, 2722G3C, and 3020insC was performed
in multiplex with a three-primer system: a biotin-labeled uni-
versal primer (5-biotin-GCTGCTCCGGTTCATAGATT-3)
and two sequence-specific primers, one of which had a univer-
sal tail (Table 1). The 50-l PCR mixtures contained 100 to
200 ng genomic DNA, 10 pmol of each sequence-specific
primer, 1 pmol of each sequence-specific primer with a uni-
versal tail and 9 pmol of the biotin-labeled universal primer,
PCR Gold Buffer (Applied Biosystems) with 2.5 mM MgCl2,
17 mM deoxynucleoside triphosphates, and 2 U Taq DNA
polymerase (Applied Biosystems).
The samples were denaturated at 94°C for 10 min and then
subjected to 40 cycles of amplification (94°C for 1 min, 62°C for
1 min, and 72°C for 1 min, with a final extension at 72°C for 7
min) in a PTC-200 thermal cycler (MJ Research). The geno-
typing results were validated by conventional sequencing.
The frequency of carriage of the Nod2 variants in patients and
controls is shown in Table 2. The frequencies of Nod2 variant
carriage were 17.5% among patients with Candida bloodstream
infections and 20% among patients with recurrent vulvovaginal
candidiasis, whereas it was 16% in healthy volunteers. We also
compared the frequencies of carriage of individual Nod2 variants
to the frequency data from other studies reporting on healthy
Dutch volunteers (Table 2). By using Fisher’s exact test, no sig-
nificant differences between Candida-infected patients and the
healthy control groups were observed.
Peripheral blood mononuclear cell (PBMC) stimulation.
Five healthy controls who were wild type for the Nod2 3020insC
polymorphism, six patients with Crohn’s disease who were wild
type for the Nod2 polymorphism and four patients with Crohn’s
disease who were homozygous for the 3020insC polymorphism
were investigated. The patients with Crohn’s disease have been
described earlier (8) and were not treated with medication prone
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to modulate cytokines (steroids, anti-tumor necrosis factor [anti-
TNF]) either before or during the experiments. Mononuclear
cells were isolated from peripheral blood by density gradient
centrifugation over Ficoll-Hypaque (Amersham Biosciences,
Sweden); washed twice in sterile phosphate-buffered saline;
and resuspended in RPMI 1640 supplemented with 10 mM
L-glutamine, gentamicin at 10 g/ml, and 10 mM pyruvate. The
cells were counted in a hemacytometer, and the number of
cells was adjusted to 5  106/ml. Heat-killed C. albicans blas-
toconidia (107 CFU/ml, strain ATCC MYA 3573), zymosan
(100 g/ml; Sigma, St. Louis, MO), Escherichia coli lipopoly-
saccharide (LPS; 1 ng/ml; Sigma), and Staphylococcus aureus
peptidoglycan (1 ng/ml; Sigma) were added to 5  105 mono-
nuclear cells in 100 l in a 96-well microtiter plate (Greiner,
Alphen a/d Rijn, The Netherlands) and were incubated for
24 h at 37°C in a 5% CO2 atmosphere.
When the PBMCs were stimulated with purified E. coli LPS
(1 ng/ml), a TLR4 ligand, the levels of production of TNF and
interleukin-10 (IL-10) in the patients homozygous for the
3020insC variant did not differ from those in patients with
Crohn’s disease or healthy volunteers with wild-type Nod2
alleles (Fig. 1A and B). The cytokine responses by cells carry-
ing the Nod2 frameshift mutation variant were not affected
after stimulation with C. albicans blastoconidia or zymosan, a
yeast cell wall particle, or TLR2 ligand. After stimulation with
PGN, cells homozygous for the frameshift mutation variant
TABLE 1. Primer sequences for detection of 2104C3T, 2722G3C, and 3020insC frameshift mutations
SNPs a used
for PCR Primer Primer sequence (5–3)
b Modification Fragmentlength (bp)
Universal primer GCTGCTCCGGTTCATAGATT Biotin
2104C3T Forward primer TTCCTGGCAGGGCTGTT 129
Reverse primer AGCGCTGCTCCGGTTCATAGATTCCAGACACCAGCGGGC
Sequence primer ACATTGGAGAAGGCCC
2722G3C Forward primer TAGAGGGAGGAGGACTGTTAGTT 140
Reverse primer AGCGCTGCTCCGGTTCATAGATTCCCCCTCGTCACCCAC
Sequence primer CTTTTAACCTTTTCA
3020insC Forward primer AGCGCTGCTCCGGTTCATAGATTTCTTCTTTTCCAGGTTGTCCA 127
Reverse primer TCCTTACCAGACTTCCAGGATG
Sequence primer TGTCATTCCTTTCAAGGG
a SNPs, single-nucleotide polymorphisms.
b Italics indicate the positions of the universal parts of the primers.
TABLE 2. Frequency of carriage of Nod2 polymorphisms in patients
with Candida bloodstream infection, patients with recurrent
vulvovaginal candidiasis, and healthy volunteers, as well
as data from Dutch healthy controls retrieved
from the literature
Group
No. of patients with the following Nod2
variants/total no. of patients tested (%) Total
(%)
2104C3T 2722G3C 3020insC
Candida bloodstream
infection (n  40)
5/40 (12.5)a 1/40 (2.5) 1/40 (2.5) 17.5
RVVC (n  15) 3/15 (20) 0/15 0/15 20
Control (n  51) 2/49b (4) 2/51 (4) 4/51 (8) 16
Controls from literature
Laine et al. (6) 10/97 (10.3) NDc 5/97 (5.2) NAd
Murillo et al. (7) ND 9/152 (5.9) 3/152 (2) NA
a One of the patients is homozygous.
b In two cases, genotyping failed.
c ND, not determined.
d NA, not applicable.
FIG. 1. Production of TNF (A) and IL-10 (B) by the PBMCs of five
healthy volunteers bearing the wild-type allele for Nod2 3020insC
variant (control), six patients with Crohn’s disease bearing the wild-
type alleles for Nod2 3020insC variant (Nod2-WT), and four patients
with Crohn’s disease homozygous for this variant (Nod2-fs). The PBMCs
were stimulated with E. coli LPS (1 ng/ml), S. aureus peptidoglycan
(1 ng/ml), heat-killed C. albicans 107 CFU/ml, and zymosan (100 g/ml).
Data are represented as means  standard errors of the means. , P
0.05, Mann-Whitney U test.
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showed significantly lower levels of TNF and IL-10 production
compared to that by Nod2 wild-type cells (Fig. 1A, B).
Stimulation of Nod1- and Nod2-transfected HEK cells. Studies
examining the activation of NF-B in cells overexpressing
Nod1 and Nod2 were carried out as described previously (2).
In brief, 1  106/ml HEK293T cells were transfected overnight
with 1 ng of either Nod1 or Nod2 plus 75 ng luciferase reporter
plasmid. At the same time, heat-killed Candida albicans was
added to cell culture medium, and the NF-B-dependent lu-
ciferase activation was measured following 24 h of incubation.
NF-B-dependent luciferase assays were performed in dupli-
cate. As shown in Fig. 2, the Candida-induced stimulation of
HEK cells transfected with Nod1 or Nod2 is similar to that of
unstimulated cells. Muramyl dipeptide (MDP; 100 nM) and dia-
mino pimelate-containing tripeptide muropeptide (TriDAP; 100
nM) served as control stimuli for Nod2 and Nod1, respectively.
The innate detection of fungal products has been shown to
involve both of the extracellular receptors TLR2 and TLR4.
We have previously shown a role of TLR4 in disseminated
Candida infections, due to decreased chemokine production
and recruitment in TLR4-defective mice challenged with an
intravenous Candida infection (9). In patients with a Candida
bloodstream infection, we have also recently demonstrated an
increased prevalence of the TLR4 Asp299Gly polymorphism,
indicating that the variant of TLR4 leads to increased suscep-
tibility to this infection (12). However, in the present study, we
demonstrate that the prevalence of Nod2 polymorphisms
among patients with Candida bloodstream infections and
women with RVVC is similar to that among healthy volun-
teers. In addition, the Nod2 3020insC frameshift polymor-
phism does not impair cytokine release in response to C. albi-
cans or fungal components. These data argue that Nod2 is
unlikely to play a major role in susceptibility to Candida infec-
tions.
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